During herpes simplex virus-1 (HSV-1) latency in sensory neurons, LAT (latency-associated transcript) is the only abundantly expressed viral gene. LAT plays an important role in the HSV-1 latency-reactivation cycle, because LAT deletion mutants have a significantly decreased reactivation phenotype. Based solely on sequence analysis, it was speculated that LAT encodes a ribozyme that plays an important role in how LAT enhances the virus' reactivation phenotype. Because LAT ribozyme activity has never been reported, we decided to test the converse hypothesis, namely, that this region of LAT does not encode a ribozyme function important for LAT's ability to enhance the reactivation phenotype. We constructed a viral mutant (LAT-Rz) in which the speculated ribozyme consensus sequence was altered such that no ribozyme was encoded. We report here that LAT-Rz had a wild-type reactivation phenotype in mice, confirming the hypothesis that the speculated LAT ribozyme is not a dominant factor in stimulating the latency-reactivation cycle in mice. Journal of NeuroVirology (2008) 14, 558Á562.
Following primary ocular herpes simplex virus type 1 (HSV-1) infection, the virus established life long latency in neurons of the trigeminal ganglia (TG). Sporadic viral reactivation in the TG can lead to shedding of virus in tears, and less often to recurrent corneal disease, a significant cause of corneal blindness due to an infectious agent (Nesburn, 1983; Smith et al, 1980) . During latency, latencyassociated transcript (LAT) is the only abundant viral transcript (Rock et al, 1987; Stevens et al, 1987) . LAT-null mutants have a significantly reduced reactivation phenotype (Hill et al, 1990; Leib et al, 1989 Leib et al, , 1991 Perng et al, 1994; Sawtell and Thompson, 1992; Steiner et al, 1989 , Trousdale et al, 1991 . Thus, LAT provides a function that directly or indirectly enhances the HSV-1 reactivation phenotype.
Restoring expression of LAT nucleotides (nts) 1 to 1499 to an otherwise LAT-null mutant can restore the reactivation phenotype to wild-type levels (Perng et al, 1996) . Thus there is a LAT function that resides completely within the first 1.5 kb of the primary 8.3-kb LAT transcript that is sufficient for supporting a wild-type reactivation phenotype. LAT has antiapoptosis activity (Ahmed et al, 2002; Carpenter et al, 2007; Kang et al, 2003; Perng et al, 2000) that appears to be a key factor in how LAT enhances the reactivation phenotype because (1) the region of LAT that can block apoptosis appears to co-map with the region of LAT (the first 1.5 kb of LAT) that enhances the reactivation phenotype (Inman et al, 2001) ; and (2) mutants in which the HSV-1 LAT gene is replaced by an alternative antiapoptosis gene have a wild-type reactivation phenotype (Jin et al, 2005 (Jin et al, , 2007 Mott et al, 2003; Perng et al, 2002) .
Theoretically, LAT's function could be due to its genomic DNA, a LAT RNA, and/or a LAT protein.
Apart from the promoter driving high levels of LAT expression, a direct DNA function is highly unlikely because plasmids or viral mutants containing just the LAT promoter or just the LAT structural region without the LAT promoter do not block apoptosis and do not have a wild-type reactivation phenotype (Hill et al, 1990; Inman et al, 2001; Jin et al, 2003; Perng et al, 1999 Perng et al, , 2000 . Thus, LAT appears to function either via one or more protein intermediaries, via one or more RNA functions, or combinations of proteins and RNAs. The search for a LAT protein has been long and extensive. Although there is a recent report of a LAT-encoded protein (Thomas et al, 2002) , this putative protein maps completely outside of the functional first 1.5 kb of LAT, suggesting that it is not critical for LAT's ability to enhance the reactivation phenotype. The first 1.5 kb of LAT contains eight potential open reading frames (ORFs), none of which are well conserved among HSV-1 LAT genes from different HSV-1 strains, suggesting that none of them are critical to LAT's function (Drolet et al, 1998) . In contrast, changing all eight initiating ATGs to TTGs in a plasmid expressing just the first 1.5 kb of LAT completely abrogated the LAT plasmid's antiapoptosis activity (Carpenter et al, 2008) . Although this suggests that one or more of these potential LAT proteins is involved in blocking apoptosis, it is also possible that introducing these point mutations altered the LAT RNA structure or stability thus altering an undetermined LAT RNA activity.
Recently a micro-RNA (miRNA) was reported to be encoded upstream of the minimal LAT promoter (Cui et al, 2006) , and interest has been raised regarding the possibility that LAT may encode one or more functional miRNAs. Consistent with this, we have recently found two small RNAs that are encoded from within the first 1.5 kb of LAT (Peng et al, 2008) . It has not yet been determined whether these small LAT RNAs are miRNAs or some other type of small RNA. Nor has it been determined whether they are involved in LAT's antiapoptosis activity or LAT's ability to enhance the reactivation phenotype.
One type of small RNA that functions without encoding a functional protein is a ribozyme. The consensus sequence ''GAA(G/A)C'' is required for ribozyme activity (Hui and Lo, 1998) . LAT contains only one such sequence ''GAAGC'' at LAT nts 1245 to 1249 (Hui and Lo, 1998) . The authors who reported this hypothesized that LAT's function was dependent on this proposed ribozyme. Although this speculated ribozyme sequence is within the first 1.5 kb of LAT, and hence within the important functional region of LAT, we are not aware of any follow-up reports in over 10 years. We therefore hypothesized that if a ribozyme is encoded by this region of LAT, it probably does not play an important role in LAT's ability to enhance the reactivation phenotype. It would be difficult to demonstrate that LAT encodes a functional ribozyme without knowing what function to examine. Without a known function, it would be even more difficult to disprove the existence of a functional LAT ribozyme. We therefore reasoned that the most direct and powerful approach to test the hypothesis that the speculated LAT ribozyme is not critical for the LAT function(s) that enhance the reactivation phenotype would be to make a viral mutant in which the speculated LAT ribozyme sequence is disrupted in both copies of LAT. We report here that reactivation of the resulting ribozyme negative LAT mutant (LAT-Rz) in the mouse explant TG reactivation model was indistinguishable from that of wild-type virus. Thus, the speculated ribozyme is not essential for LAT's ability to enhance the HSV-1 reactivation phenotype in mice.
The consensus ribozyme sequence ''GAAGC'' at LAT nts 1245 to 1249 was changed to ''TAAGC'' using site directed mutagenic primers and a twostep polymerase chain reaction (PCR) reaction. Two PCR fragments were generated that overlap by 35 bp of identical sequence. This overlap contains the above alteration to the ribozyme consensus sequence. The two fragments were mixed in equal amounts and joined together by PCR. The resulting 445 bp long fragment contained a KpnI restriction site at the 5' end and an XcmI restriction site at the 3' end, with the mutated ribozyme consensus sequence in between. The fragment was cloned into the KpnI/XcmI restriction sites of a cloned HpaI/SalI fragment of McKrae DNA that overlaps the putative ribozyme site by over 800 bp on both ends. The mutated 445-bp region was then sequenced to confirm that the HpaI/SalI fragment contained the mutated ribozyme consensus site. This plasmid was designated LAT3.9Rz (Figure 1) . The LAT3.9Rz plasmid was then used to restore the entire LAT region from LAT nts (161 to '1667 in both copies of the LAT region of the LAT( () mutant dLAT2903 (Figure 1 ). This was achieved by homologous recombination following cotransfection of RS cells with the plasmid and purified genomic dLAT2903 DNA. Viral plaques were screened with a StyI-StyI probe (LAT nts 76 to 447) for reintroduction of the LAT region into the dLAT2903 virus, as we previously described for construction of other LAT mutants (Jin et al, 2005; Perng et al, 1994) . Following nine rounds of plaque purification, a viral stock was grown and subjected to Southern blot analysis to confirm that both copies of LAT had been restored to dLAT2903 by the mutated LAT region (Figure 2) . DNA was digested with SalI and the DNA fragments separated on a 0.8% agarose gel, denatured, and transferred to a nylon membrane for Southern blot analysis. A HpaI-HpaI DNA fragment (LAT nts (1800 to '1499) was radiolabeled with a-32 P-dCTP by nick translation and used as a probe. SalI digestion produces a LAT DNA fragment from LAT in the terminal long repeat that is larger than the LAT DNA fragment from the internal long repeat, thus allowing us to look at the status of both copies of LAT. The enzyme cuts both copies of LAT at LAT nt 2102 and then cuts in the unique long region. The SalI site in the unique long region near the terminal long repeat is 8768 nts away from LAT nt 2102 in the terminal long repeat, whereas the SalI site in the unique long region near the internal long repeat is 6387 nts away from LAT nt 2102 in the internal long repeat. Thus, as seen in Figure 2 , the wild-type LAT fragments are 8768 and 6387 bp, whereas the dLAT2903 LAT fragments are each 1829 nts shorter (6939 and 4558 bp) due to the EcoRV ((161) to HpaI (1667) deletion in both copies of LAT. As shown in lane ''Rz,'' homologous recombination with the plasmid containing the mutated ribozyme site restored both LAT regions to their wild-type mobility, indicating that the viral mutant, LAT-Rz, contains a mutation in the putative LAT ribozyme sequence in both copies of LAT. This mutation renders both LAT regions incapable of encoding a functional ribozyme.
Replication of LAT-Rz in tissue culture was similar to replication of wild-type virus (not shown). To determine the effect of the putative LAT ribozyme knockout on the HSV-1 reactivation phenotype, Swiss-Webster mice were infected with 2)10 5 plaque-forming units (PFU)/eye of LAT-Rz, its immediate parental virus the LAT deletion mutant dLAT2903, or HSV-1 strain McKrae, the parental wild-type virus from which dLAT2903 was constructed. Acute eye disease (not shown) and survival (58% to 72%, P!.05) were similar with all three viruses.
Mouse TG explant reactivation was performed as previously described . Briefly, 30 days post infection mice were euthanized, TG were removed, and individual TG, each cut into approximately 10 to 12 pieces, were plated in 6-well tissue culture plates in standard tissue culture medium (MEM) with 10% fetal calf serum (FCS). An aliquot of medium was removed daily from each well and plated onto monolayers of rabbit skin cells, which were then monitored for the appearance of cytopathic effects (CPEs) indicative of the presence of reactivated virus. Figure 3 . Consistent with previous studies (Perng et al, 1994 ), reactivation of dLAT2903 was significantly reduced compared to wild-type McKrae (P 0.046 by survival curve analysis). Reactivation of LAT-Rz was indistinguishable from wild-type virus (P 0.93) and was significantly greater than dLAT2903 (P0.034). Thus, the putative LAT ribozyme did not appear to be essential for LAT's ability to support the wild-type reactivation phenotype. The speculated LAT ribozyme site mutated in this report was noted almost 10 years ago based on sequence analysis of the LAT region (Hui and Lo, 1998) . At that time, it was proposed that LAT encoded a functional ribozyme that plays a significant role in how LAT affects the reactivation phenotype. The proposed LAT ribozyme site is located within a larger region of LAT that is involved in LAT's ability to enhance the virus' reactivation phenotype (Perng et al, 1994 (Perng et al, , 1996 . However, because these mutants affect a much larger region than the small potential ribozyme site, they do not demonstrate that this ribozyme site is important as was previously suggested (Hui and Lo, 1998) . To our knowledge, the LAT-Rz mutant in this report is the only mutant that directly targets the potential ribozyme site. Because the predicted LAT ribozyme site has been abrogated in LAT-Rz without any detectable alteration to the HSV-1 reactivation phenotype, it appears that the predicted ribozyme is not essential for LAT's ability to enhance the HSV-1 reactivation phenotype in mice.
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References
A putative ribozyme site encoded within LAT 561 D Carpenter et al
